✦ LIBER ✦

Feasibility and Efficacy of High-Dose Melphalan, Cyclophosphamide, Etoposide, and Dexamethasone (LEED) Chemotherapy with or without Rituximab Followed by Autologous Stem Cell Transplantation for Aggressive and Relapsed Non-Hodgkin’s Lymphoma

✍ Scribed by Li-na Han; Jin Zhou; Takayuki Hirose; Yosuke Imai; Takuro Ishiguro; Takaaki Chou

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BEAC or BEAM high-dose chemotherapy foll

✍ Jae-Cheol Jo; Byung Wook Kang; Geundoo Jang; Sun Jin Sym; Sung Sook Lee; Ja Eun 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 144 KB

Phase II study of a salvage regimen usin

✍ Yasuhiro Oki; Michinori Ogura; Harumi Kato; Ako Kikuchi; Hirofumi Taji; Yoshitoy 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Safety and feasibility of CHOP/rituximab

✍ Heß, G; Flohr, T; Huber, C; Kolbe, K; Derigs, H-G; Fischer, T 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB

A randomized trial of chemotherapy with

✍ J.-P. Glossmann; A. Josting; B. Pfistner; U. Paulus; A. Engert; German Hodgkin's 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 90 KB

Four versus six courses of a dose-escala

✍ Nobert Schmitz; Marita Kloess; Marcel Reiser; Wolfgang E. Berdel; Bernd Metzner; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB